Catéter Venoso Totalmente Implantável em 278 Pacientes Oncológicos
DOI:
https://doi.org/10.32635/2176-9745.RBC.2000v46n1.3401Palavras-chave:
Cateter Totalmente Implantável, Câncer, Acesso Venoso Longa Permanência, CatéterResumo
Os catéteres totalmente implantáveis proporcionam acesso vascular prolongado, baixo risco durante inserção e remoção, fácil manutenção, conforto e segurança para o paciente e baixo índice de complicações. Nosso objetivo é relatar a experiência com 278 catéteres implantados por um único cirurgião. Foram critérios para o implante: diagnóstico histopatológico, expectativa de vida maior que 3 meses, dificuldade de acesso venoso periférico e programa de quimioterapia. Entre março de 1990 e março 1998 foram implantados 278 catéteres em 272 pacientes. Tempo de permanência: 382 dias (5a 2897) totalizando 106.457 dias. Sexo feminino 64.8%. Idade média 50,2 anos. Via de acesso: jugular interna 67,9%, jugular externa 26,5%, safena 2,2%, cefálica 1,7% e subclávia 1.7%. Complicações: #1. Obstrução (0,26/1000 dias) #2. Hematoma 6,11% do total, todos em pacientes leucêmicos. #3. Extravasamento 0,2/1000 dias). #4. Trombose (0,03/1000 dias). #5. Infecção 20 episódios, 0,19/1000 dias), sendo 6 lúmen, 7 peri-port e 7 suspeita clínica de sepses. Foram retirados 34 catéteres, 26 por complicações e 8 ao término do tratamento. Permanecem vivos em uso do cateter 45,2%. Não apresentaram qualquer tipo de complicação 74,5% dos pacientes. Em nossa experiência o número de complicações é baixo. O manuseio é realizado exclusivamente por profissionais treinados. Atenção com pacientes leucêmicos para a formação de hematomas.
Downloads
Referências
RICHARD ALEXANER, ALICE B. LUCAS, ELIZABETH P. STEINHAUS, MICFFAELTOROSIAN. Vascular access in the cancer patient. 1th Ed. J. B. Lippincott Company 1994, pg 19
AUBANIAC R: Injection intraveineuse sous-claviculaire. Avantages et technique. Press Med 60: 1456, 1952.
BROVIACJW, COLEJJ, SCHRIBNERBH. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet 1973; 136: 602-606
HICKMAM RO, BUCKNER CD, CEIFE RA, SANDERS JE, STEWART P, THOMAS ED. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 1979; 148: 871-875
NIEDERHUBERJE, ENSMINGERW, GYVES JW, LIPERMAN M, DOAN K, COZZIE. TotaUy implanted venous and arterial access system to replace externai cath eters in câncer tratment. Surgery 1982; 92: 706-712
BROTHERS TE, VON MOLE LK, NIEDERHUBER JE, ROBERTS JÁ, WALKER-REWS S, ENSMINGER WD. Experience with subcutaneous infusion ports in three hundred patients. Surg Gynecol Obstet 1988; 166: 295-301.
ROSS MN, HAASE GM, POOLE MA, BURLINGTON JD, ODOM LF. Comparison oftotally implanted reservoirs with externai catheters as venous access devices in pediatric oncologic patients. Surg Gynecol Obstet 1988;167:141-144 .
GREENE FL, MOORE W, STRICKL G, MCFARL J. Comparison of a totally implantable access device for chemotherapy (Port-A-Cath) and long-term percutaneous catheterization (Broviac). Couth Med J 1988; 81: 580-603
GREENE FL, MOORE W, STRICKL G, MCFARL J. Comparison of a totally implantable access device for chemotherapy (Port-A-Cath) and long-term percutaneous catheterization (Broviac). Couth Med J 1988; 81: 580-603. DOI: https://doi.org/10.1097/00007611-198805000-00010
THOMPSON WR, ALEXANDER HR, MARTIN AJ, FLETCHER JR, GROSH BC. Percutaneous subclavian catheterization for prolonged systemic chemoterapy. J Surg Oncol 1985; 29: 184-186 DOI: https://doi.org/10.1002/jso.2930290311
MIRRO et al. A comparision of placement techniques and complications of extenalized and implantable port use in children with câncer. J Pediatr Surg 1990; 25: 120- 124 DOI: https://doi.org/10.1016/S0022-3468(05)80176-9
REED WR NEWMAN KA. A improved technique for the insertion of Hickman catheters in patients with thrombocytopenia and granulocitopenia. Surg Ginecol Obstet 1983; 156: 355-358
YAKOUN M, JOYEUX H, SOLASSOL C. catheterization of internal jugular vein for total parenteral nutrition. World] Surg 1982; 6: 369-371 DOI: https://doi.org/10.1007/BF01653561
JANSEN RFM, WIGGERS T, VAN GEEL BN, VAN PUTTEN WLJ. Assesment of insertion techniques and complication rates of dual lumen central venous cath eters in patients with hematological malignances. World L Surg 1988; 12: 509-510
SAGOR G, MITCHENERE P, LAYFIELD J, PRENTICE HG, KIRIK RM. Prolonged acess to the venous system using the Hickman right atrial catheter. Ann R Coll Surg Engl 1983; 65: 47-49
GUENIERC, FERREIRA], PECTORJC. Prolonged venous access in cancer patients. Eur J Surg Oncol 1989: 15: 553-555
CLARKE DE, RAFFINTA, Infectious complications of indwelling long-term central venous catheters. Chest 1990; 97: 966-972 DOI: https://doi.org/10.1378/chest.97.4.966
SEVERIAN C, NELSON J. Frequency of infections associated with implanted Systems vs cuffed, tunneled silastic catheters in patientes with acute leukemia. Am J Dis Child 1991; 145: 1433-1438 DOI: https://doi.org/10.1001/archpedi.1991.02160120101028
INGRAM J, WEITZMAN S, GREENBERG ML, PARKIN P, FILER R. Complications of indwelling venous acess lines in the pediatric hematology patients: a prospective comparision of external venous catheter and subcutaneous port. AM J Pediatr Hematol Oncol 1991; 13: 130-136 DOI: https://doi.org/10.1097/00043426-199122000-00003
MUELLER et al. A prospective randomized trial comparing the infectious and noninfectious complications of na externalized cathter versus a subcutaneously im planted device in cancer patients. J Clin Oncol 1992; 12: 1943-1948 DOI: https://doi.org/10.1200/JCO.1992.10.12.1943
PEGUES et al. Comparison of infections in Hickman and implanted port catheters in adult solid tumor patients. J Surg Oncol 1992; 49: 156-162 DOI: https://doi.org/10.1002/jso.2930490306
KEUNG et al. Comparative study of infectious complications of different types of ebronie central venous access device. Câncer 1994; 73: 2832-2837 DOI: https://doi.org/10.1002/1097-0142(19940601)73:11<2832::AID-CNCR2820731128>3.0.CO;2-V
BRAR KA, MURRAY DL, LEADERI. Central venous catheter infections in pediatric patients in a communitary bospital. Infection 1988; 16: 86-90 DOI: https://doi.org/10.1007/BF01644309
HARTMAN GE SHOCHAT SJ. Management of sptic complications associated witb Silastic catbeters in cbildbood malignancy. Pediatr Infect Dis J 1987;6: 1042-1047 DOI: https://doi.org/10.1097/00006454-198706110-00009
STUART RK; SHIKORA AS; AKERMAN P; et al; Incidence of arrtytmia witb venous catheter insertion end exebange. JPEN 14:152-155, 1990 DOI: https://doi.org/10.1177/0148607190014002152
SHULMAN et al. Use of hypocloric acid to clear obstructec central venous catheters. JPEN 1988; 12: 509-510 DOI: https://doi.org/10.1177/0148607188012005509
PENNINGTON CR, PITHIE AD. Ethanol lock in tbe management of cateter occlusion. JPEN 1987; 11: 507-508 DOI: https://doi.org/10.1177/0148607187011005507
WACHS T. Urokinase administration in pediatric pa tients witb occluded central venous catbeters. JIN 1990; 13: 100-102
LAWSON M, BOTTINO JC, HURTUBISE MR, MCCREDIE BCB. The use of urokinase to restore the pathency of occluded central venous catheters. AMJ Inttraven Tber Clin Nutr 1982; 5: 29-32
MOSS JF, WAGMAN LD, RIIHIMAKIDU, TERZ JJ. Central venous thrombosis related to silastic Hickman-Broviac catheters in na oncologic population. JPEN 1989; 13: 397-400 DOI: https://doi.org/10.1177/0148607189013004397
KRAMER FL, GOODMAN J, ALLEN S. Thrombolytic tberapy in catbeter-related subclavian venous trombosis. J Can Assoe Radiol 1987; 38: 106-108
STILLMAN RM, SOLIMAN R GARCIA L, SAWYER PN. Etiology of catbeter-associated sepsis. Arch Surg 1977; 112: 1497-1499 DOI: https://doi.org/10.1001/archsurg.1977.01370120087011
SWEED M, GUENTER P, LUCENTE K, et al. Long-term central venous catbeters in patients with acquired immunodeficiency syndrome. Am-J-Infect-Contol 1995; 23: 194-9 DOI: https://doi.org/10.1016/0196-6553(95)90041-1
EASTRIDGE BJ. LEFOR AT. Complications of indwelling venous access devices in cancer patients. J Clin-Oncol 1995; 13: 233-8 DOI: https://doi.org/10.1200/JCO.1995.13.1.233
KRUPSKIG, FROSCHLE. GW, WEH FJ, et al. Cen tral venous access devices in treatment of patients with malignant tumors; venous port, central venous catbeter and Hickman catbeter. Cost-experiences with 135 port implantatios and patient attitude. Chirurg 1995; 66: 202-7
BARNES. Wbew sbould tbe “infected” subcutaneous infusion reservoir be removed? Am-Surg. 1996; 62: 203-6
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
